Orthonika Analysis: $7M Raised
What is Orthonika?
Orthonika specializes in the development of the Total Meniscus Replacement implant, addressing irreparable meniscus injuries. Their technology aims to alleviate pain and restore mobility, targeting a significant clinical need in orthopaedics. The company focuses on replicating native meniscus biomechanics to improve patient outcomes.
Location
168 Shoreditch High Street, 2nd Floor, London, England E1 6RA, United Kingdom
Employees
1-10
Founded
2014
Funding Status
Series A
Product Features & Capabilities
- Total Meniscus Replacement implant
- Proprietary technology for meniscus injury treatment
Use Cases
Reduce pain for patients with irreparable meniscus injuries; Restore mobility in patients post-meniscectomy; Provide anatomical support mimicking native meniscus function; Address high rates of osteoarthritis following meniscectomy; Serve healthcare providers performing meniscus interventions
HQ Full Address
168 Shoreditch High Street, 2nd Floor, London, England E1 6RA, United Kingdom
Other Considerations
Over 2 million meniscus interventions performed globally each year; Over 80% of meniscus injuries remain irreparable; High rates of meniscectomy lead to increased risk of osteoarthritis
See something that needs updating? Suggest edits to this profile.